Wird geladen...
Advances in Anti-IgE Therapy
Omalizumab depletes free IgE in the blood and interstitial space and inhibits IgE binding to FcεRI on basophils, mast cells, and dendritic cells. We stopped omalizumab treatment after four years. Recurrences of urticaria symptoms were found to be higher in patients with chronic urticaria than recurr...
Gespeichert in:
| Veröffentlicht in: | Biomed Res Int |
|---|---|
| 1. Verfasser: | |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Hindawi Publishing Corporation
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4436440/ https://ncbi.nlm.nih.gov/pubmed/26075226 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/317465 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|